Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00751634 · ClinicalTrials.gov registry record · Phase 4

Temperature Control in Central Fever in the Neuro-ICU

A Phase 4 study of Fever and Brain Hemorrhage, sponsored by Northwestern University.

Completed
Registry status
Phase 4
Development phase
20
Enrollment target
1
Study location

NCT00751634 is a Phase 4 study of Fever and Brain Hemorrhage that has completed, run by Northwestern University. The registered enrollment target is 20 participants, below the 598-participant average among 18 other Fever trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00751634, a Phase 4 study of Fever and Brain Hemorrhage, has completed, sponsored by Northwestern University.

COMPLETED
Registry status
Phase 4
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

There are few treatments for central fever (fever that is due to the central nervous system, as opposed to an infectious source). We hypothesize that an externally applied cooling blanket will reduce temperature in neurologically ill patients with central fever.

Conditions Studied

Interventions

  • DEVICE Gaymar Rapr-Round (external cooling blanket)

Study Locations (1)

Illinois

  • Northwestern Memorial Hospital - Chicago

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2009-01
Est. Completion 2011-01
Phase Phase 4

Sponsor

Northwestern University

1,209 total trials

What the Registry Record Tells You About NCT00751634

The ClinicalTrials.gov registry entry for NCT00751634 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 598-participant average among 18 other Fever trials with a reported enrollment target (97% lower). The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Fever appearing as the primary indexed condition, and to 1 intervention - of which Gaymar Rapr-Round (external cooling blanket) is the first listed.

NCT00751634 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT00751634 about?

NCT00751634 is a clinical study titled "Temperature Control in Central Fever in the Neuro-ICU". There are few treatments for central fever (fever that is due to the central nervous system, as opposed to an infectious source). We hypothesize that an externally applied cooling blanket will reduce temperature in neurologically ill patients with central fever.

What is the current status of trial NCT00751634?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2009-01. Estimated completion is 2011-01.

What conditions does trial NCT00751634 study?

This clinical trial studies the following conditions: Fever, Brain Hemorrhage.

What interventions are being tested in trial NCT00751634?

The interventions under investigation include: Gaymar Rapr-Round (external cooling blanket) (DEVICE).

Who is sponsoring clinical trial NCT00751634?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00751634 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Fever

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.